Scarica l'app Stockscreener
33.33
0.57%
0.19
Dopo l'orario di chiusura:
33.33
Precedente Chiudi:
$33.14
Aprire:
$32.52
Volume 24 ore:
985.91K
Relative Volume:
1.01
Capitalizzazione di mercato:
$3.58B
Reddito:
-
Utile/perdita netta:
$-167.80M
Rapporto P/E:
-20.42
EPS:
-1.6323
Flusso di cassa netto:
$-144.07M
1 W Prestazione:
+5.31%
1M Prestazione:
+12.22%
6M Prestazione:
+122.20%
1 anno Prestazione:
+114.76%
Intervallo 1D:
$32.26
$33.55
Intervallo di 1 settimana:
$29.71
$33.55
Portata 52W:
$10.60
$33.55
Edgewise Therapeutics Inc Stock (EWTX) Company Profile
Nome
Edgewise Therapeutics Inc
Settore
Industria
Telefono
720-262-7002
Indirizzo
1715 38TH ST, BOULDER
Compare EWTX vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EWTX
Edgewise Therapeutics Inc
|
33.33 | 3.58B | 0 | -167.80M | -144.07M | -1.6323 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Edgewise Therapeutics Inc Stock (EWTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-25 | Iniziato | Goldman | Neutral |
| 2025-07-30 | Iniziato | Raymond James | Strong Buy |
| 2025-06-30 | Iniziato | H.C. Wainwright | Buy |
| 2025-04-30 | Iniziato | Guggenheim | Buy |
| 2025-04-02 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-07 | Iniziato | Scotiabank | Sector Outperform |
| 2025-01-22 | Iniziato | Stifel | Hold |
| 2024-11-22 | Iniziato | Evercore ISI | Outperform |
| 2024-03-07 | Iniziato | Piper Sandler | Overweight |
| 2023-05-01 | Iniziato | Truist | Buy |
| 2022-08-25 | Downgrade | Goldman | Neutral → Sell |
| 2022-04-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-01-28 | Iniziato | Goldman | Neutral |
Mostra tutto
Edgewise Therapeutics Inc Borsa (EWTX) Ultime notizie
Breakouts Watch: Is Edgewise Therapeutics Inc subject to activist investor interest2026 Action & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
SG Americas Securities LLC Buys 78,842 Shares of Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Breakout Move: Is Edgewise Therapeutics Inc being accumulated by smart moneyMarket Performance Summary & Daily Technical Forecast Reports - baoquankhu1.vn
Director at Edgewise Therapeutics (EWTX) awarded 339 new shares - Stock Titan
Edgewise Therapeutics stock hits 52-week high at 33.5 USD By Investing.com - Investing.com Canada
Edgewise Therapeutics, Inc. (EWTX) PT increased to $45 at JPMorgan amid optimism on EDG-7500 pipeline - MSN
Edgewise Therapeutics (NASDAQ:EWTX) CMO Joanne Donovan Sells 28,662 Shares - MarketBeat
Edgewise Therapeutics CMO sells $926,095 in EWTX stock By Investing.com - Investing.com Canada
Edgewise Therapeutics Insider Sold Shares Worth $926,095, According to a Recent SEC Filing - MarketScreener
[Form 4] Edgewise Therapeutics, Inc. Insider Trading Activity - Stock Titan
Edgewise Therapeutics (NASDAQ:EWTX) Sets New 52-Week HighHere's What Happened - MarketBeat
Hedge Fund Bets: Is Edgewise Therapeutics Inc exposed to currency risksQuarterly Market Summary & Stepwise Trade Signal Implementation - baoquankhu1.vn
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules - ChartMill
EWTX PE Ratio & Valuation, Is EWTX Overvalued - intellectia.ai
Edgewise Therapeutics CMO sells $685k in EWTX stock By Investing.com - Investing.com Canada
Edgewise Therapeutics (EWTX) CMO sells 21,338 shares after option exercise - Stock Titan
Fund Flows: Is Edgewise Therapeutics Inc trading at a discount2026 Intraday Action & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Insider Sell Alert: Joanne Donovan Sells 16,358 Shares of Edgewi - GuruFocus
Insider Sell Alert: Joanne Donovan Sells 16,358 Shares of Edgewise Therapeutics Inc (EWTX) - GuruFocus
Edgewise Therapeutics CMO Donovan sells $506k in EWTX stock By Investing.com - Investing.com Canada
Edgewise Therapeutics (NASDAQ: EWTX) CMO sells 16,358 shares in open market - Stock Titan
Edgewise Therapeutics, Inc. (EWTX) PT Increased to $45 at JPMorgan Amid Optimism on EDG-7500 Pipeline - Yahoo Finance
EWTX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
(EWTX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
EWTX (NASDAQ) Form 144 lists 71,588 shares from options, ESPP, RSUs - stocktitan.net
Aug Analyst Calls: Can Edgewise Therapeutics Inc reach all time highs this year2026 Major Catalysts & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
Edgewise Therapeutics stock reaches 52-week high at $31.86 By Investing.com - Investing.com Australia
Edgewise Therapeutics (NASDAQ:EWTX) Reaches New 12-Month HighHere's Why - MarketBeat
Edgewise Therapeutics stock reaches 52-week high at $31.86 - Investing.com
Why Edgewise Therapeutics Stock Topped the Market on Tuesday - AOL.com
A Look At Edgewise Therapeutics (EWTX) Valuation After Promising Sevasemten Becker Muscular Dystrophy Data - Sahm
EWTX SEC FilingsEdgewise Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Edgewise Therapeutics team to attend 2026 American College of Cardiology annual meeting - Traders Union
Trading Recap: Can Edgewise Therapeutics Inc keep up with sector leaders2026 Price Targets & Free Community Supported Trade Ideas - baoquankhu1.vn
Why Edgewise Therapeutics stock topped the market on Tuesday - MSN
Inflation Data: What analysts say about Edgewise Therapeutics Inc stock2026 Spike Watch & Stepwise Swing Trade Plans - baoquankhu1.vn
How (EWTX) Movements Inform Risk Allocation Models - Stock Traders Daily
Death Cross: Is Edgewise Therapeutics Inc being accumulated by smart money2026 Action & Verified Short-Term Plans - baoquankhu1.vn
Edgewise Therapeutics Inc (EWTX) Stock Price, Quote, News & History - Benzinga
Why Edgewise Therapeutics Stock Topped the Market on Tuesday - The Motley Fool
JPMorgan Chase & Co. Raises Edgewise Therapeutics (NASDAQ:EWTX) Price Target to $45.00 - MarketBeat
JPMorgan raises Edgewise Therapeutics price target on pipeline outlook By Investing.com - Investing.com Canada
Edgewise Therapeutics' (EWTX) "Outperform" Rating Reiterated at Wedbush - MarketBeat
Is Edgewise Therapeutics Inc being accumulated by smart money2026 Action & Verified Short-Term Plans - baoquankhu1.vn
The $3B Biotech With Two Shots On Goal - Benzinga
Assessing Edgewise Therapeutics (EWTX) Valuation After Encouraging Long Term MESA Study Results - Yahoo Finance
Granahan Investment Management Trims Edgewise Therapeutics Holdings - National Today
HighVista Strategies Boosts Edgewise Therapeutics Stake - National Today
Edgewise Therapeutics, Inc. $EWTX Shares Purchased by HighVista Strategies LLC - MarketBeat
First Light Asset Management Reduces Stake in Edgewise Therapeutics - National Today
Granahan Investment Management LLC Trims Stock Holdings in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Edgewise Therapeutics Inc Azioni (EWTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):